APA

Maisnar V., Stefanikova Z., Spicka I., Pour L., Minarik J., Flochova E., Radocha J., Gregora E., Stecova N., Jelinek T., Jungova A., Kralikova E., Brozova L. & Hajek R. (20190909). Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. : Neoplasma.

Chicago

Maisnar V, Stefanikova Z, Spicka I, Pour L, Minarik J, Flochova E, Radocha J, Gregora E, Stecova N, Jelinek T, Jungova A, Kralikova E, Brozova L and Hajek R. 20190909. Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. : Neoplasma.

Harvard

Maisnar V., Stefanikova Z., Spicka I., Pour L., Minarik J., Flochova E., Radocha J., Gregora E., Stecova N., Jelinek T., Jungova A., Kralikova E., Brozova L. and Hajek R. (20190909). Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. : Neoplasma.

MLA

Maisnar V, Stefanikova Z, Spicka I, Pour L, Minarik J, Flochova E, Radocha J, Gregora E, Stecova N, Jelinek T, Jungova A, Kralikova E, Brozova L and Hajek R. Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. : Neoplasma. 20190909.